This is how they define themselves:
In 1983, one man’s dream gave birth to Jyothy Labs in Thrissur, Kerala. MP Ramchandran had one goal: touching and bettering lives with innovation. From manufacturing and selling a single product to a household name in the category, Jyothy Labs has come a long way. With a turnover of about Rs . 1,800 Crores, we continue to grow as one of the country’s most trusted brands. Our products are priced affordably, packaged exceptionally and distributed nationally.

> It is a small cap company with a market cap of just Rs . 5,855 Cr . Not very small though.
> The ROCE is at 17.8% and ROE is at 15% which is good considering the size of the company.
> Stock P/E is at 29 which makes the valuation attractive as compared to the main competitor HUL P/E at 69.
> It is almost a debt free company, reducing its borrowings continuously on year on year basis, that's a very good sign from investment perspective.
> Topline and bottomline both are very impressive.
> Company has been maintaining a healthy dividend payout of 65%
> It is increasing it's cash reserve on YOY basis, currently have huge cash reserve as compared to its borrowings.
> The company has maintained its Operating Profit Margin (OPM) at or above 15% since last 5 years, that's again a positive sign.
> Holdings: Promoters holding are intact at 62.89, FIIs and DIIs both have huge stake in the company very recently as compared to the it's pears.
> Popular Brands: Henko, Ujala, Mr White, Maxo, Pril & Margo

> Stock looking very good on chart, its making rounding bottom pattern, one of the very profitable chart pattern and it is about to give breakout.
> Trading above 100 DMA and about to break 200 DMA.
> It is clear from volume at the bottom that lot of accumulation is going on in the company and bull run is around the corner.

Fresh Buy - At CMP i.e. 158.
Old Buy - HOLD
First Target - 201
Second Target - 241

Happy Investing!
Team ShareMktSchool
Comment: CMP is 184, those who have taken entries enjoy the profit but keep holding tight.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.